May 1, 2021
[Archive] Vision Meeting: Advances in Managing Retinal Disease
The treatment of retinal diseases continue to evolve, providing the potential to enhance visual acuity and patient outcomes when incorporated in practice; however, staying up-to-date with these advances can be challenging. During this virtual meeting, experts in the field will review and discuss the progress being made in the management of retinal disease.
Objectives:
-Evaluate data from recent clinical trials of diabetic retinopathy treatments
-Discuss management strategies for dry and wet age-related macular degeneration
-Describe biosimilars that are being utilized and studied for retinal diseases
Objectives:
-Evaluate data from recent clinical trials of diabetic retinopathy treatments
-Discuss management strategies for dry and wet age-related macular degeneration
-Describe biosimilars that are being utilized and studied for retinal diseases
Meeting archives
Non-Commercial/Non-Sponsored Clinical Presentation
Current Management of Dry and Wet Age-Related Macular Degeneration (AMD)
Speaker: Joshua Dunaief, MD, PhD
Sponsored Clinical Presentation
Advancing ONS-5010 for Approval: Ophthalmic Formulation of Bevacizumab for Retinal Disease
Speaker: Jeff Evanson
Non-Commercial/Non-Sponsored Clinical Presentation
New Directions in Treating Diabetic Retinopathy
Speaker: Elia Duh, MD
Non-Commercial/Non-Sponsored Clinical Presentation
The Rise in Biosimilars for Retinal Diseases
Speaker: Baruch Kuppermann, MD